Future Pak Increases Bid for Vanda Pharmaceuticals to Include CVRs in Addition to $7.25 to $7.75 Per Share in Cash [Yahoo! Finance]
Vanda Pharmaceuticals Inc. (VNDA)
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-irhome
Company Research
Source: Yahoo! Finance
Offer represents $11.62 to $12.12 per share, for a 187% to 199% unaffected premium, when combining the proposed cash consideration and potential value of the CVRs Future Pak remains committed to a transaction despite actions by Vanda to limit stockholder influence and its refusal to engage constructively WIXOM, Mich., May 07, 2024 BUSINESS WIRE )--Future Pak LLC ("Future Pak") confirms it increased its offer for all outstanding shares of common stock of Vanda Pharmaceuticals ("Vanda" or "the Company") (NYSE: VNDA) to include Contingent Value Rights ("CVRs") in addition to the cash consideration of $7.25 to $7.75 per share (the "Revised Proposal"), representing a potential increase of approximately $4.37 per share from the prior proposal announced on April 17, 2024. This increased offer, assuming full triggering of the CVRs, represents a premium of 140% to 150% to Vanda's closing share price of $4.84 on May 6, 2024 and a premium of 187% to 199% to the Company's unaffected share pr
Show less
Read more
Impact Snapshot
Event Time:
VNDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNDA alerts
High impacting Vanda Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
VNDA
News
- Vanda (VNDA) Rises on Positive Data From Motion Sickness Study [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals reports positive data from motion sickness trial [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion SicknessPR Newswire
- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
VNDA
Earnings
- 5/8/24 - Miss
VNDA
Sec Filings
- 5/13/24 - Form DEFA14A
- 5/9/24 - Form DEFA14A
- 5/9/24 - Form 10-Q
- VNDA's page on the SEC website